These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38048331)

  • 1. Prostacyclin in Moscow.
    Martin J
    Cardiovasc Res; 2024 Feb; 120(1):e1. PubMed ID: 38048331
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting prostacyclin: all gain with no pain?
    Rondina MT
    Blood; 2023 Nov; 142(18):1506-1507. PubMed ID: 37917084
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
    Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
    Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Prostacyclin Analogues for Frostbite Require Careful Monitoring.
    Bello JW; Rickrode GA; Harlan NP; Buckey JC
    J Burn Care Res; 2023 Mar; 44(2):487-488. PubMed ID: 36444642
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose systemic phosphodiesterase III inhibitor pimobendan combined with prostacyclin therapy in a patient with severe primary pulmonary hypertension.
    Watanabe E; Shiga T; Matsuda N; Kajimoto K; Naganuma M; Kawai A; Kasanuki H
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):375-9. PubMed ID: 14696637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin among prostanoids.
    Gryglewski RJ
    Pharmacol Rep; 2008; 60(1):3-11. PubMed ID: 18276980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in children: acute endotheliopathy, but forgotten prostacyclin replacement?
    Schranz D
    Cardiol Young; 2022 Apr; 32(4):572-573. PubMed ID: 34227929
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of nebulized epoprostenol and iloprost on hemoglobin oxygen affinity: an ex vivo experiment.
    Woyke S; Mair N; Haller T; Ronzani M; Plunser D; Oberacher H; Gatterer H; Rugg C; Ströhle M
    Am J Physiol Lung Cell Mol Physiol; 2022 Jun; 322(6):L898-L903. PubMed ID: 35503651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.
    Lang IM; Gaine SP
    Eur Respir Rev; 2015 Dec; 24(138):630-41. PubMed ID: 26621977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019: Erratum.
    Pediatr Crit Care Med; 2024 Mar; 25(3):e175. PubMed ID: 38451807
    [No Abstract]   [Full Text] [Related]  

  • 11. Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection.
    Vinokurova M; Lopes-Pires ME; Cypaite N; Shala F; Armstrong PC; Ahmetaj-Shala B; Elghazouli Y; Nüsing R; Liu B; Zhou Y; Hao CM; Herschman HR; Mitchell JA; Kirkby NS
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):271-286. PubMed ID: 37823267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient.
    Li Z; Luo W; Fang S; Chen X; Lin T; Zhou S; Zhang L; Yang W; Li Z; Ye J; Wang J; Liu P; Li Z
    Acta Physiol (Oxf); 2021 Feb; 231(2):e13555. PubMed ID: 32886850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertension.
    Ewert R; Habedank D; Halank M; Stubbe B; Opitz CF
    Expert Rev Respir Med; 2022 Jan; 16(1):57-66. PubMed ID: 34846985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New regional drug delivery system by direct epicardial placement of slow-release prostacyclin agonist promise therapeutic angiogenesis in a porcine chronic myocardial infarction.
    Miyagawa S; Mizoguchi H; Fukushima S; Imanishi Y; Watabe T; Harada A; Sakai Y; Sawa Y
    J Artif Organs; 2021 Dec; 24(4):465-472. PubMed ID: 33761039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling.
    Vanderpool RR; Insel M; Kubba S; Rischard FP
    Am J Respir Crit Care Med; 2023 Apr; 207(8):1100-1102. PubMed ID: 36689755
    [No Abstract]   [Full Text] [Related]  

  • 16. Muscle Injuries Induce a Prostacyclin-PPARγ/PGC1a-FAO Spike That Boosts Regeneration.
    Luo L; Chua YB; Liu T; Liang K; Chua MJ; Ma W; Goh JW; Wang Y; Su J; Ho YS; Li CW; Liu KH; Teh BT; Yu K; Shyh-Chang N
    Adv Sci (Weinh); 2023 Jul; 10(21):e2301519. PubMed ID: 37140179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.
    Falcetti E; Flavell DM; Staels B; Tinker A; Haworth SG; Clapp LH
    Biochem Biophys Res Commun; 2007 Sep; 360(4):821-7. PubMed ID: 17624303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclin.
    Bunting S; Moncada S; Reed P; Salmon JA; Vane JR
    Prostaglandins; 1978 Apr; 15(4):565-73. PubMed ID: 353902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture.
    Kamio K; Sato T; Liu X; Sugiura H; Togo S; Kobayashi T; Kawasaki S; Wang X; Mao L; Ahn Y; Holz O; Magnussen H; Rennard SI
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1226-32. PubMed ID: 18424619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoprostenol, alias prostacyclin.
    Phillips GF
    Lancet; 1982 Sep; 2(8300):723-4. PubMed ID: 6126660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.